Marc E. Vuylsteke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Marc E. Vuylsteke has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Serge Mordon
Hemerion Therapeutics, 59650 Villeneuve d’Ascq, France
9 shared publications Geneviève Guillaume
Department of Cardiovascular and Thoracic Surgery, University Hospital Mont-Godinne, Yvoir, Belgium
2 shared publicationsI. Fourneau
2 shared publicationsIvan Staelens
Department of Vascular Surgery, University Hospital of Brussels, Brussels, Belgium
2 shared publicationsP. Mahieu
Department of Vascular Surgery, Sint-Andriesziekenhuis, Tielt, Belgium
2 shared publications- Roos Colman
Biostatistics Unit, Faculty of Medicine and Health Sciences Ghent University Ghent Belgium
2 shared publications
Latest Publications
- 30 January 2026
- Published by SAGE Publications in Angiology
Molecular Factors Involved in the Mechanism of Intimal Hyperplasia: A Systematic Review
Intimal hyperplasia (IH) results from excessive vascular smooth muscle cell (VSMC) proliferation, migration through the internal elastic lamina, and extracellular matrix (ECM) protein deposition, orchestrated by various physical and molecular factors in the vasculature. IH is a common complication following endovascular treatments or angioplasty procedures and remains poorly managed despite decades of research. Although many molecular factors contributing to IH have been identified over recent years, earlier studies have not fully integrated these discoveries. Recent research has largely concentrated on VSMC proliferation, migration, and dedifferentiation. This review aims to comprehensively elucidate the molecular pathways involved in all stages of IH development, including endothelial injury, the coagulation cascade, inflammation, ECM deposition, and vascular remodeling, to inform future therapeutic strategies. We extensively searched PubMed for relevant animal studies reporting molecular mechanism involved in formation of IH and included 56 articles. In total, we found 69 molecules and 6 pathways involved in all stages of IH. Among the molecular pathways involved, the Mitogen-activated Protein Kinase (MAPK), Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB), and Transforming Growth Factor Beta (TGF-β).pathways consistently emerge in almost each step of IH development. This highlights the need for a multifaceted and comprehensive treatment to prevent IH.
- 30 January 2026
- Published by SAGE Publications in Angiology
Molecular Factors Involved in the Mechanism of Intimal Hyperplasia: A Systematic Review
Intimal hyperplasia (IH) results from excessive vascular smooth muscle cell (VSMC) proliferation, migration through the internal elastic lamina, and extracellular matrix (ECM) protein deposition, orchestrated by various physical and molecular factors in the vasculature. IH is a common complication following endovascular treatments or angioplasty procedures and remains poorly managed despite decades of research. Although many molecular factors contributing to IH have been identified over recent years, earlier studies have not fully integrated these discoveries. Recent research has largely concentrated on VSMC proliferation, migration, and dedifferentiation. This review aims to comprehensively elucidate the molecular pathways involved in all stages of IH development, including endothelial injury, the coagulation cascade, inflammation, ECM deposition, and vascular remodeling, to inform future therapeutic strategies. We extensively searched PubMed for relevant animal studies reporting molecular mechanism involved in formation of IH and included 56 articles. In total, we found 69 molecules and 6 pathways involved in all stages of IH. Among the molecular pathways involved, the Mitogen-activated Protein Kinase (MAPK), Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB), and Transforming Growth Factor Beta (TGF-β).pathways consistently emerge in almost each step of IH development. This highlights the need for a multifaceted and comprehensive treatment to prevent IH.
- 1 June 2022
- Published by Edizioni Minerva Medica in International Angiology
- Vol. 41 (3) , 232-239
Management of chronic venous disease in general practice: a cross-sectional study of first line care in Belgium
Article: Management of chronic venous disease in general practice: a cross-sectional study of first line care in Belgium - International Angiology 2022 Feb 18 - Minerva Medica - Journals
- 1 June 2022
- Published by Edizioni Minerva Medica in International Angiology
- Vol. 41 (3) , 232-239
Management of chronic venous disease in general practice: a cross-sectional study of first line care in Belgium
Article: Management of chronic venous disease in general practice: a cross-sectional study of first line care in Belgium - International Angiology 2022 Feb 18 - Minerva Medica - Journals
- 1 March 2019
- Published by Edizioni Minerva Medica in International Angiology
- Vol. 38 (1) , 22-38
Endovenous ablation
Varicose vein surgery is among the most commonly performed surgical interventions. The standard treatment 'high ligation and stripping' has in many countries been replaced by endovenous techniques. However, there are many different techniques available. All have a different way of action and sometimes need different skills. The purpose of this review article is to give an update in those different endovenous ablation techniques. We describe the indications, technique, mechanisms of action, and results. We conclude that all different techniques can be used safely and are effective. Even on long term there seems to be no difference in outcome, even compared to high ligation and stripping.
- 1 March 2019
- Published by Edizioni Minerva Medica in International Angiology
- Vol. 38 (1) , 22-38
Endovenous ablation
Varicose vein surgery is among the most commonly performed surgical interventions. The standard treatment 'high ligation and stripping' has in many countries been replaced by endovenous techniques. However, there are many different techniques available. All have a different way of action and sometimes need different skills. The purpose of this review article is to give an update in those different endovenous ablation techniques. We describe the indications, technique, mechanisms of action, and results. We conclude that all different techniques can be used safely and are effective. Even on long term there seems to be no difference in outcome, even compared to high ligation and stripping.
- 26 February 2018
- Published by SAGE Publications in Angiology
- Vol. 69 (9) , 779-785
An Epidemiological Survey of Venous Disease Among General Practitioner Attendees in Different Geographical Regions on the Globe: The Final Results of the Vein Consult Program
This study measured the prevalence of chronic venous disease (CVD, C1-C6), chronic venous insufficiency (C3-C6) in 23 countries. The possible influence of risk factors was assessed. Patient recruitment was carried out by general practitioners. Patient characteristics, prevalence of risk factors, and C-classification were recorded. We assessed differences in prevalence and risk factors between Asia (A), Eastern Europe (EE), Latin America (LA), and Western Europe (WE). A total of 99 359 patients were included. The prevalence of CVD (51.9% A, 70.18% EE, 68.11% LA, and 61.65% WE) was significantly (P < .001) lower in A. Risk factors such as age, obesity, smoking, having regular exercise, use of birth control pills, prolonged standing and sitting, and having a positive family history differ significantly between regions. After model-based probabilities corrected for risk factors, significant differences in the probability of having CVD were only found in the older age-group (>65 years). The lowest prevalence was noted in A. Chronic venous disease is very common and the prevalence varies between different geographical areas. After correcting for risk factors, these differences diminished.
- 26 February 2018
- Published by SAGE Publications in Angiology
- Vol. 69 (9) , 779-785
An Epidemiological Survey of Venous Disease Among General Practitioner Attendees in Different Geographical Regions on the Globe: The Final Results of the Vein Consult Program
This study measured the prevalence of chronic venous disease (CVD, C1-C6), chronic venous insufficiency (C3-C6) in 23 countries. The possible influence of risk factors was assessed. Patient recruitment was carried out by general practitioners. Patient characteristics, prevalence of risk factors, and C-classification were recorded. We assessed differences in prevalence and risk factors between Asia (A), Eastern Europe (EE), Latin America (LA), and Western Europe (WE). A total of 99 359 patients were included. The prevalence of CVD (51.9% A, 70.18% EE, 68.11% LA, and 61.65% WE) was significantly (P < .001) lower in A. Risk factors such as age, obesity, smoking, having regular exercise, use of birth control pills, prolonged standing and sitting, and having a positive family history differ significantly between regions. After model-based probabilities corrected for risk factors, significant differences in the probability of having CVD were only found in the older age-group (>65 years). The lowest prevalence was noted in A. Chronic venous disease is very common and the prevalence varies between different geographical areas. After correcting for risk factors, these differences diminished.
- Open Access
- 5 October 2015
- Published by SAGE Publications in Phlebology: The Journal of Venous Disease
- Vol. 31 (6) , 440-441
Concerning the publication: “Histological difference between pulsed wave laser and continuous wave laser in endovenous laser ablation” by Kansaku R, Sakakibara N, Amano A, Endo H, Shimabukuro T, Sueishi M. Phlebology 2015; 30: 429–434
- 5 October 2015
- Published by SAGE Publications in Phlebology: The Journal of Venous Disease
- Vol. 31 (6) , 440-441
Open AccessConcerning the publication: “Histological difference between pulsed wave laser and continuous wave laser in endovenous laser ablation” by Kansaku R, Sakakibara N, Amano A, Endo H, Shimabukuro T, Sueishi M. Phlebology 2015; 30: 429–434
- 1 June 2015
- Published by SAGE Publications in Phlebology: The Journal of Venous Disease
- Vol. 31 (5) , 325-333
The influence of age and gender on venous symptomatology. An epidemiological survey in Belgium and Luxembourg
The aim of this study is to measure the incidence of the symptoms in patients with chronic venous disease (CVD) and to look for the influence of age on the severity of symptoms for both genders. A survey was carried out in Belgium and Luxembourg between May and September 2013. Patient recruitment was done by 406 general practitioners (GPs). Each GP screened 10–20 consecutive patients older than 18 years. Inquiries were made regarding the presence of symptoms and possible signs of CVD. Patients with diagnosed CVD filled out a questionnaire including a quality of life score (CIVIQ-14). These data were converted into a CIVIQ Global Index Score (GIS). Statistical analysis was performed in order to calculate the effect of age and gender on the number of symptoms and the estimated probabilities of having CVD. Totally 6009 patients were included in this survey. The mean age was 53.4 years. Of all, 61.3% of the patients have CVD (C1-C6). Of all, 64.7% of patients were symptomatic. Age and female gender were major risk factors for developing CVD. Most common symptoms were ‘heavy legs’ (70.4%), pain (54.0%), and sensation of swelling (52.7%). The number of symptoms increases with age (p < 0.001). Female patients have significantly more symptoms in comparison with male patients in all age groups. In both females and males, age is negatively correlated with GIS score (p < 0.001). The estimated probability of having CVD was significantly higher for woman compared to men and increases with age for both gender. CVD is a very common progressive disease with age as a major risk factor. Increasing age results in a higher C-classification, more symptoms, and a lower GIS score (quality of life). Female gender interacts significantly with age and results in a more advanced stage of CVD.
- 1 June 2015
- Published by SAGE Publications in Phlebology: The Journal of Venous Disease
- Vol. 31 (5) , 325-333
The influence of age and gender on venous symptomatology. An epidemiological survey in Belgium and Luxembourg
The aim of this study is to measure the incidence of the symptoms in patients with chronic venous disease (CVD) and to look for the influence of age on the severity of symptoms for both genders. A survey was carried out in Belgium and Luxembourg between May and September 2013. Patient recruitment was done by 406 general practitioners (GPs). Each GP screened 10–20 consecutive patients older than 18 years. Inquiries were made regarding the presence of symptoms and possible signs of CVD. Patients with diagnosed CVD filled out a questionnaire including a quality of life score (CIVIQ-14). These data were converted into a CIVIQ Global Index Score (GIS). Statistical analysis was performed in order to calculate the effect of age and gender on the number of symptoms and the estimated probabilities of having CVD. Totally 6009 patients were included in this survey. The mean age was 53.4 years. Of all, 61.3% of the patients have CVD (C1-C6). Of all, 64.7% of patients were symptomatic. Age and female gender were major risk factors for developing CVD. Most common symptoms were ‘heavy legs’ (70.4%), pain (54.0%), and sensation of swelling (52.7%). The number of symptoms increases with age (p < 0.001). Female patients have significantly more symptoms in comparison with male patients in all age groups. In both females and males, age is negatively correlated with GIS score (p < 0.001). The estimated probability of having CVD was significantly higher for woman compared to men and increases with age for both gender. CVD is a very common progressive disease with age as a major risk factor. Increasing age results in a higher C-classification, more symptoms, and a lower GIS score (quality of life). Female gender interacts significantly with age and results in a more advanced stage of CVD.
- Open Access
- 5 December 2012
- Published by Springer Nature
Endovenous laser treatment of the great saphenous vein using a bare fibre versus tulip fibre
- 5 December 2012
- Published by Springer Nature
Open AccessEndovenous laser treatment of the great saphenous vein using a bare fibre versus tulip fibre
- 1 December 2012
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 44 (6) , 587-592
Endovenous Laser Ablation of the Great Saphenous Vein Using a Bare Fibre versus a Tulip Fibre: A Randomised Clinical Trial
- 1 December 2012
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 44 (6) , 587-592
Endovenous Laser Ablation of the Great Saphenous Vein Using a Bare Fibre versus a Tulip Fibre: A Randomised Clinical Trial